Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
QRX003 is a topical lotion formulated with Invisicare®, a proprietary delivery technology, and contains a broad-spectrum serine protease inhibitor. It is being developed for the treatment of netherton syndrome.
Lead Product(s): QRX003
Therapeutic Area: Rare Diseases and Disorders Product Name: QRX003
Highest Development Status: Phase II/ Phase IIIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 14, 2024